Alterations in Endocrine Function
Overview
Learning Objectives
Explain the pathophysiology of endocrine function.
Explore epidemiological and etiological risk factors that contribute to
clients experiencing alterations in endocrine function.
Describe the impact of alterations in endocrine function on a client’s
overall health.
Differentiate the clinical presentation of clients experiencing
alterations in endocrine function.
Explore the role of the nurse when caring for clients experiencing
alterations in endocrine function.
Apply the nursing process through the use of clinical judgment
functions while providing care to clients experiencing alterations in
endocrine function.
The endocrine system is a major regulatory system of the human
body. Glands communicate with the body through the secretion
of hormones. Hormones, which are composed of biochemical substances,
bind with specific target receptors and are necessary for cellular
metabolism (glucose control, energy production, and utilization), body
growth, development, responses to injury or stress, and reproduction.
Hormones are stored in and released from the endocrine system glands,
such as the hypothalamus, pituitary, thyroid, parathyroid, adrenals,
pancreas, ovaries, testes, and pineal glands. Disorders, disruptions, or
imbalances of the endocrine system usually involve increases or decreases
in the production of a hormone or the failure of a target cellular receptor.
Nurses must understand the endocrine system because of its complex
interaction with other body systems.
,M1.5 ATI Engage AMS Alterations in Endocrine Function
The hypothalamus is located deep in the brain and coordinates the
endocrine system through the production and release of hormones. The
major role of the hypothalamus is to maintain the body’s homeostasis. It is
the hypothalamus that links the endocrine system with the nervous system
and secretes hormones to regulate the pituitary gland. The hypothalamus
controls the pituitary gland’s release of hormones and detects hormone
levels as they work together in a feedback relationship called
the hypothalamic-pituitary axis. The hormones involved include thyroid-
stimulating hormone (TSH), follicle-stimulating hormone (FSH), luteinizing
hormone (LH), growth hormone, prolactin, and adrenocorticotropic
hormone.
The pituitary gland is a small pea-sized gland just below the hypothalamus
connected by a pituitary stalk (also known as infundibulum). One of the
pituitary gland’s main responsibilities is secreting hormones to stimulate or
regulate most of the other endocrine glands, such as TSH. This hormone is
produced in the anterior pituitary and is released to stimulate the thyroid
gland to release thyroid hormones. The hypothalamus and the pituitary
gland regulate many body functions, such as body temperature (through
TSH thyrotropin-releasing hormone), fluid balance (antidiuretic hormone or
vasopressin), blood pressure (dopamine), appetite, stress (cortisol), sleep
,M1.5 ATI Engage AMS Alterations in Endocrine Function
(melatonin via the pineal gland), and reproductive health (gonadotropin-
releasing hormone).
The adrenal glands are located on the superior aspect of each kidney and
are responsible for secreting cortisol and aldosterone. Alterations in these
hormones can result in disorders such as Addison’s disease and Cushing’s
syndrome. Addison’s disease is a disorder of the adrenal glands in which the
glands are damaged and unable to produce adequate amounts of cortisol
and aldosterone. An insufficient amount of these hormones diminishes the
body’s ability to maintain metabolism, electrolyte balance, blood pressure,
and blood glucose levels and also creates an inability to control
inflammation. Cushing’s syndrome is a disorder in which excessive amounts
of cortisol are excreted. This results in associated health problems such as
hypertension, osteoporosis, metabolic syndrome, diabetes, and increased
risk for infections.
This module will focus on major disorders of the pancreas and thyroid
glands, including hyperglycemia, hypoglycemia, type 1 and type 2 diabetes
mellitus, metabolic syndrome, hypothyroidism, and hyperthyroidism.
This module will:
Explain the pathophysiology.
Explore epidemiological and etiological risk factors that can
contribute to alterations in endocrine function.
Describe the impact of alterations in endocrine function on a client’s
overall health.
Differentiate the clinical presentation of clients experiencing
alterations in endocrine function.
Explore the role of the nurse and explain how to use the nursing
process to manage care when caring for clients experiencing
alterations in endocrine function.
, M1.5 ATI Engage AMS Alterations in Endocrine Function
Hyperglycemia
Anatomy, Physiology, and Pathophysiology
The pancreas is an endocrine gland that is approximately six inches long
and pear-shaped. It lies transverse across the upper abdomen, behind the
stomach, with the wider end (head) on the lower right side. The pancreas is
connected to the duodenum by the pancreatic duct. The thinner end (tail) is
connected on the left toward the spleen. The pancreas has two main
functions in the endocrine system. The first function is as an endocrine
gland, secreting the hormone insulin in beta glands or glucagon to regulate
blood glucose levels. The second function is as an exocrine gland, secreting
enzymes for digestion such as amylase and lipase. Glucagon is released in
response to blood glucose levels to prevent hypoglycemia. Insulin is the key
hormone that unlocks the cell to allow the absorption of glucose.
Glucose is the main source of fuel for the body and brain and requires
insulin to move across cell membranes into cells. Insulin is an essential
hormone that is produced in the beta cells of the pancreas. Hyperglycemia
is defined by a fasting blood glucose concentration greater than 126 mg/dL.
Insulin is produced in the islets of Langerhans from beta cells.
Hyperglycemia is a hallmark of type 1 diabetes mellitus (DMT1) and type 2
diabetes mellitus (DMT2). Insulin resistance is a failure of the insulin
receptors, which are located on the membrane of the target cells, to accept
insulin. Also, cell receptors may become insulin resistant, or the pancreas
gradually loses its ability to produce enough insulin.